UBI Pharma, Inc.

FDA 483 - UBI Pharma, Inc.

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore UBI Pharma, Inc.

Record Details

UBI Pharma Inc., a drug product manufacturer in Hsinchu County, Taiwan, was cited for significant deficiencies in its laboratory control system and manufacturing processes. Observations included incomplete raw data records lacking final conclusive results for various tests, as well as the absence of final summary reports for stability and environmental monitoring data. Additionally, executed batch records failed to document and justify deviations in manufacturing parameters, specifically regarding vial capping speeds.

Company: UBI Pharma, Inc.
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
People: David Gomes (Microbiologist)
Kham Phommachanh (Investigator)

Open in Dashboard

ID · b39cf96c-6b57-40cf-9438-9ae2289de3b8